nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—type 2 diabetes mellitus—atherosclerosis	0.72	1	CtDrD
Linagliptin—ABCB1—Ezetimibe—atherosclerosis	0.0331	0.152	CbGbCtD
Linagliptin—ABCB1—Simvastatin—atherosclerosis	0.0308	0.141	CbGbCtD
Linagliptin—ABCB1—Pravastatin—atherosclerosis	0.0301	0.138	CbGbCtD
Linagliptin—ABCB1—Lovastatin—atherosclerosis	0.0301	0.138	CbGbCtD
Linagliptin—CYP3A4—Rosuvastatin—atherosclerosis	0.0198	0.0909	CbGbCtD
Linagliptin—CYP3A4—Ezetimibe—atherosclerosis	0.0198	0.0909	CbGbCtD
Linagliptin—CYP3A4—Simvastatin—atherosclerosis	0.0184	0.0845	CbGbCtD
Linagliptin—CYP3A4—Pravastatin—atherosclerosis	0.018	0.0827	CbGbCtD
Linagliptin—CYP3A4—Lovastatin—atherosclerosis	0.018	0.0827	CbGbCtD
Linagliptin—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.00124	0.0235	CcSEcCtD
Linagliptin—Skin exfoliation—Niacin—atherosclerosis	0.00103	0.0196	CcSEcCtD
Linagliptin—Diabetes mellitus—Simvastatin—atherosclerosis	0.000981	0.0186	CcSEcCtD
Linagliptin—Pain in extremity—Lovastatin—atherosclerosis	0.000913	0.0173	CcSEcCtD
Linagliptin—Pancreatitis—Rosuvastatin—atherosclerosis	0.000913	0.0173	CcSEcCtD
Linagliptin—Diabetes mellitus—Niacin—atherosclerosis	0.000901	0.0171	CcSEcCtD
Linagliptin—Pain in extremity—Ezetimibe—atherosclerosis	0.000895	0.017	CcSEcCtD
Linagliptin—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000807	0.0153	CcSEcCtD
Linagliptin—Nasopharyngitis—Ezetimibe—atherosclerosis	0.0008	0.0152	CcSEcCtD
Linagliptin—Pancreatitis—Lovastatin—atherosclerosis	0.000773	0.0147	CcSEcCtD
Linagliptin—Pancreatitis—Ezetimibe—atherosclerosis	0.000759	0.0144	CcSEcCtD
Linagliptin—Pancreatitis—Simvastatin—atherosclerosis	0.000723	0.0137	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000719	0.0137	CcSEcCtD
Linagliptin—Nasopharyngitis—Pravastatin—atherosclerosis	0.00069	0.0131	CcSEcCtD
Linagliptin—Infestation NOS—Ezetimibe—atherosclerosis	0.00069	0.0131	CcSEcCtD
Linagliptin—Infestation—Ezetimibe—atherosclerosis	0.00069	0.0131	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000686	0.013	CcSEcCtD
Linagliptin—Urinary tract infection—Lovastatin—atherosclerosis	0.000684	0.013	CcSEcCtD
Linagliptin—Pancreatitis—Pravastatin—atherosclerosis	0.000654	0.0124	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00062	0.0118	CcSEcCtD
Linagliptin—Weight increased—Pravastatin—atherosclerosis	0.000607	0.0115	CcSEcCtD
Linagliptin—Angioedema—Rosuvastatin—atherosclerosis	0.000593	0.0113	CcSEcCtD
Linagliptin—Urinary tract infection—Pravastatin—atherosclerosis	0.000578	0.011	CcSEcCtD
Linagliptin—Cough—Rosuvastatin—atherosclerosis	0.000566	0.0107	CcSEcCtD
Linagliptin—Immune system disorder—Ezetimibe—atherosclerosis	0.000559	0.0106	CcSEcCtD
Linagliptin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000558	0.0106	CcSEcCtD
Linagliptin—Myalgia—Rosuvastatin—atherosclerosis	0.000552	0.0105	CcSEcCtD
Linagliptin—Arthralgia—Rosuvastatin—atherosclerosis	0.000552	0.0105	CcSEcCtD
Linagliptin—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.000549	0.0587	CbGpPWpGaD
Linagliptin—Malnutrition—Ezetimibe—atherosclerosis	0.000539	0.0102	CcSEcCtD
Linagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—atherosclerosis	0.000536	0.0573	CbGpPWpGaD
Linagliptin—Back pain—Lovastatin—atherosclerosis	0.000532	0.0101	CcSEcCtD
Linagliptin—Infection—Rosuvastatin—atherosclerosis	0.000526	0.00999	CcSEcCtD
Linagliptin—Back pain—Ezetimibe—atherosclerosis	0.000521	0.0099	CcSEcCtD
Linagliptin—Angioedema—Lovastatin—atherosclerosis	0.000502	0.00954	CcSEcCtD
Linagliptin—Angioedema—Ezetimibe—atherosclerosis	0.000493	0.00935	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000482	0.00916	CcSEcCtD
Linagliptin—DPP4—Incretin synthesis, secretion, and inactivation—LEP—atherosclerosis	0.000477	0.051	CbGpPWpGaD
Linagliptin—Malnutrition—Niacin—atherosclerosis	0.000472	0.00896	CcSEcCtD
Linagliptin—Cough—Ezetimibe—atherosclerosis	0.00047	0.00893	CcSEcCtD
Linagliptin—Angioedema—Simvastatin—atherosclerosis	0.00047	0.00892	CcSEcCtD
Linagliptin—Myalgia—Lovastatin—atherosclerosis	0.000468	0.00889	CcSEcCtD
Linagliptin—Arthralgia—Lovastatin—atherosclerosis	0.000468	0.00889	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.00046	0.0492	CbGpPWpGaD
Linagliptin—Myalgia—Ezetimibe—atherosclerosis	0.000459	0.00872	CcSEcCtD
Linagliptin—Arthralgia—Ezetimibe—atherosclerosis	0.000459	0.00872	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000456	0.00866	CcSEcCtD
Linagliptin—Constipation—Rosuvastatin—atherosclerosis	0.000453	0.0086	CcSEcCtD
Linagliptin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000449	0.00852	CcSEcCtD
Linagliptin—Infection—Lovastatin—atherosclerosis	0.000446	0.00846	CcSEcCtD
Linagliptin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00044	0.00836	CcSEcCtD
Linagliptin—Myalgia—Simvastatin—atherosclerosis	0.000438	0.00831	CcSEcCtD
Linagliptin—Arthralgia—Simvastatin—atherosclerosis	0.000438	0.00831	CcSEcCtD
Linagliptin—Infection—Ezetimibe—atherosclerosis	0.000437	0.0083	CcSEcCtD
Linagliptin—Angioedema—Niacin—atherosclerosis	0.000431	0.00819	CcSEcCtD
Linagliptin—Skin disorder—Ezetimibe—atherosclerosis	0.000427	0.00812	CcSEcCtD
Linagliptin—Angioedema—Pravastatin—atherosclerosis	0.000425	0.00807	CcSEcCtD
Linagliptin—Urticaria—Rosuvastatin—atherosclerosis	0.00042	0.00799	CcSEcCtD
Linagliptin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00042	0.00797	CcSEcCtD
Linagliptin—Infection—Simvastatin—atherosclerosis	0.000417	0.00792	CcSEcCtD
Linagliptin—Cough—Niacin—atherosclerosis	0.000412	0.00782	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000409	0.00776	CcSEcCtD
Linagliptin—Cough—Pravastatin—atherosclerosis	0.000406	0.0077	CcSEcCtD
Linagliptin—Myalgia—Niacin—atherosclerosis	0.000402	0.00763	CcSEcCtD
Linagliptin—Arthralgia—Niacin—atherosclerosis	0.000402	0.00763	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000401	0.00761	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000399	0.00758	CcSEcCtD
Linagliptin—Myalgia—Pravastatin—atherosclerosis	0.000396	0.00751	CcSEcCtD
Linagliptin—Arthralgia—Pravastatin—atherosclerosis	0.000396	0.00751	CcSEcCtD
Linagliptin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00039	0.00741	CcSEcCtD
Linagliptin—Anaphylactic shock—Niacin—atherosclerosis	0.000385	0.00732	CcSEcCtD
Linagliptin—Constipation—Lovastatin—atherosclerosis	0.000384	0.00728	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000382	0.00726	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00038	0.00721	CcSEcCtD
Linagliptin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000379	0.0072	CcSEcCtD
Linagliptin—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.000377	0.0404	CbGpPWpGaD
Linagliptin—Infection—Pravastatin—atherosclerosis	0.000377	0.00716	CcSEcCtD
Linagliptin—Constipation—Ezetimibe—atherosclerosis	0.000376	0.00714	CcSEcCtD
Linagliptin—Skin disorder—Niacin—atherosclerosis	0.000374	0.00711	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000362	0.00688	CcSEcCtD
Linagliptin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000362	0.00688	CcSEcCtD
Linagliptin—Constipation—Simvastatin—atherosclerosis	0.000359	0.00681	CcSEcCtD
Linagliptin—Urticaria—Lovastatin—atherosclerosis	0.000356	0.00677	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000351	0.00667	CcSEcCtD
Linagliptin—Urticaria—Ezetimibe—atherosclerosis	0.000349	0.00664	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000346	0.00656	CcSEcCtD
Linagliptin—Rash—Rosuvastatin—atherosclerosis	0.000334	0.00634	CcSEcCtD
Linagliptin—Dermatitis—Rosuvastatin—atherosclerosis	0.000333	0.00633	CcSEcCtD
Linagliptin—Urticaria—Simvastatin—atherosclerosis	0.000333	0.00633	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000333	0.00632	CcSEcCtD
Linagliptin—Headache—Rosuvastatin—atherosclerosis	0.000332	0.0063	CcSEcCtD
Linagliptin—Hypersensitivity—Lovastatin—atherosclerosis	0.00033	0.00628	CcSEcCtD
Linagliptin—Constipation—Pravastatin—atherosclerosis	0.000324	0.00616	CcSEcCtD
Linagliptin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000324	0.00616	CcSEcCtD
Linagliptin—Hypersensitivity—Simvastatin—atherosclerosis	0.000309	0.00587	CcSEcCtD
Linagliptin—Diarrhoea—Lovastatin—atherosclerosis	0.000307	0.00583	CcSEcCtD
Linagliptin—Urticaria—Niacin—atherosclerosis	0.000306	0.00581	CcSEcCtD
Linagliptin—Urticaria—Pravastatin—atherosclerosis	0.000301	0.00572	CcSEcCtD
Linagliptin—Diarrhoea—Ezetimibe—atherosclerosis	0.000301	0.00572	CcSEcCtD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000287	0.0307	CbGpPWpGaD
Linagliptin—Diarrhoea—Simvastatin—atherosclerosis	0.000287	0.00545	CcSEcCtD
Linagliptin—Hypersensitivity—Niacin—atherosclerosis	0.000284	0.00539	CcSEcCtD
Linagliptin—Rash—Lovastatin—atherosclerosis	0.000283	0.00537	CcSEcCtD
Linagliptin—Dermatitis—Lovastatin—atherosclerosis	0.000283	0.00537	CcSEcCtD
Linagliptin—Headache—Lovastatin—atherosclerosis	0.000281	0.00534	CcSEcCtD
Linagliptin—Hypersensitivity—Pravastatin—atherosclerosis	0.000279	0.00531	CcSEcCtD
Linagliptin—Rash—Ezetimibe—atherosclerosis	0.000277	0.00527	CcSEcCtD
Linagliptin—Dermatitis—Ezetimibe—atherosclerosis	0.000277	0.00526	CcSEcCtD
Linagliptin—Headache—Ezetimibe—atherosclerosis	0.000276	0.00523	CcSEcCtD
Linagliptin—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.000271	0.0289	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—GHRL—atherosclerosis	0.000269	0.0287	CbGpPWpGaD
Linagliptin—Rash—Simvastatin—atherosclerosis	0.000265	0.00502	CcSEcCtD
Linagliptin—Dermatitis—Simvastatin—atherosclerosis	0.000264	0.00502	CcSEcCtD
Linagliptin—Diarrhoea—Niacin—atherosclerosis	0.000264	0.00501	CcSEcCtD
Linagliptin—Headache—Simvastatin—atherosclerosis	0.000263	0.00499	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—ACE—atherosclerosis	0.00026	0.0278	CbGpPWpGaD
Linagliptin—Diarrhoea—Pravastatin—atherosclerosis	0.00026	0.00493	CcSEcCtD
Linagliptin—Rash—Niacin—atherosclerosis	0.000243	0.00461	CcSEcCtD
Linagliptin—Dermatitis—Niacin—atherosclerosis	0.000243	0.00461	CcSEcCtD
Linagliptin—Headache—Niacin—atherosclerosis	0.000241	0.00458	CcSEcCtD
Linagliptin—Rash—Pravastatin—atherosclerosis	0.000239	0.00454	CcSEcCtD
Linagliptin—Dermatitis—Pravastatin—atherosclerosis	0.000239	0.00454	CcSEcCtD
Linagliptin—Headache—Pravastatin—atherosclerosis	0.000238	0.00451	CcSEcCtD
Linagliptin—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.000234	0.025	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCG4—atherosclerosis	0.000229	0.0245	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCG8—atherosclerosis	0.00022	0.0235	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000182	0.0195	CbGpPWpGaD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.000177	0.0189	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCG1—atherosclerosis	0.000174	0.0186	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—AGT—atherosclerosis	0.000165	0.0176	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000165	0.0176	CbGpPWpGaD
Linagliptin—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.000162	0.0173	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—LEP—atherosclerosis	0.000162	0.0173	CbGpPWpGaD
Linagliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.000149	0.0159	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000143	0.0153	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—INS—atherosclerosis	0.000138	0.0148	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCG5—atherosclerosis	0.000136	0.0146	CbGpPWpGaD
Linagliptin—DPP4—Peptide hormone metabolism—IGF1—atherosclerosis	0.000134	0.0143	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.000121	0.0129	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000112	0.012	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000102	0.0109	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	8.8e-05	0.00941	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PLA2G7—atherosclerosis	8.69e-05	0.00929	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	8.52e-05	0.00911	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—HSPD1—atherosclerosis	7.06e-05	0.00755	CbGpPWpGaD
Linagliptin—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	6.98e-05	0.00746	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	6.45e-05	0.0069	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	6.37e-05	0.00681	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	5.96e-05	0.00638	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	5.91e-05	0.00631	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	5.89e-05	0.00629	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—F7—atherosclerosis	5.69e-05	0.00609	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	5.29e-05	0.00566	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	5.25e-05	0.00561	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	5.23e-05	0.00559	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL17A—atherosclerosis	5.1e-05	0.00546	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—GHRL—atherosclerosis	5.07e-05	0.00543	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—ACE—atherosclerosis	4.91e-05	0.00525	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	4.88e-05	0.00522	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	4.83e-05	0.00517	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CD40—atherosclerosis	4.53e-05	0.00484	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PLAUR—atherosclerosis	4.41e-05	0.00472	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—PLG—atherosclerosis	4.31e-05	0.00461	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	4.3e-05	0.0046	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	4.14e-05	0.00443	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	4.05e-05	0.00433	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGF2—atherosclerosis	3.93e-05	0.0042	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	3.64e-05	0.00389	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL10—atherosclerosis	3.47e-05	0.00371	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	3.47e-05	0.00371	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	3.3e-05	0.00352	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—FASLG—atherosclerosis	3.23e-05	0.00345	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—MMP1—atherosclerosis	3.15e-05	0.00337	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—AGT—atherosclerosis	3.12e-05	0.00333	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	3.07e-05	0.00328	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—LEP—atherosclerosis	3.05e-05	0.00326	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	3.01e-05	0.00322	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	2.93e-05	0.00313	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—F2—atherosclerosis	2.88e-05	0.00308	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	2.78e-05	0.00297	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	2.74e-05	0.00293	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—INS—atherosclerosis	2.61e-05	0.00279	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	2.59e-05	0.00277	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	2.57e-05	0.00275	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CCL2—atherosclerosis	2.57e-05	0.00274	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	2.53e-05	0.00271	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—IGF1—atherosclerosis	2.52e-05	0.0027	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—MMP2—atherosclerosis	2.44e-05	0.00261	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	2.4e-05	0.00256	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	2.3e-05	0.00246	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	2.22e-05	0.00237	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IFNG—atherosclerosis	2.04e-05	0.00218	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—CXCL8—atherosclerosis	2.03e-05	0.00217	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	1.9e-05	0.00203	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—IL1B—atherosclerosis	1.82e-05	0.00195	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	1.82e-05	0.00194	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	1.79e-05	0.00191	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	1.78e-05	0.0019	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	1.65e-05	0.00176	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	1.59e-05	0.0017	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	1.54e-05	0.00165	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	1.48e-05	0.00158	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	1.43e-05	0.00152	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	1.41e-05	0.00151	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	1.34e-05	0.00144	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—TNF—atherosclerosis	1.32e-05	0.00141	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LDLRAP1—atherosclerosis	1.32e-05	0.00141	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLTP—atherosclerosis	1.24e-05	0.00133	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	1.16e-05	0.00124	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.15e-05	0.00123	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	1.14e-05	0.00121	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.13e-05	0.00121	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LTA4H—atherosclerosis	1.08e-05	0.00115	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG8—atherosclerosis	1.08e-05	0.00115	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	1.05e-05	0.00113	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	9.65e-06	0.00103	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	9.3e-06	0.000994	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG1—atherosclerosis	8.51e-06	0.00091	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	8.38e-06	0.000896	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	8.23e-06	0.00088	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	8.13e-06	0.00087	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—FABP4—atherosclerosis	8e-06	0.000855	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LCAT—atherosclerosis	8e-06	0.000855	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	7.91e-06	0.000845	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA4—atherosclerosis	7.85e-06	0.000839	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP7A1—atherosclerosis	7.71e-06	0.000825	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLTP—atherosclerosis	7.65e-06	0.000818	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	7.6e-06	0.000813	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.3e-06	0.00078	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	7.19e-06	0.000769	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP27A1—atherosclerosis	7.13e-06	0.000762	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	6.99e-06	0.000747	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	6.98e-06	0.000746	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALOX15—atherosclerosis	6.76e-06	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALOX5AP—atherosclerosis	6.76e-06	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	6.76e-06	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA2—atherosclerosis	6.76e-06	0.000723	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCG5—atherosclerosis	6.68e-06	0.000714	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG8—atherosclerosis	6.63e-06	0.000709	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LTA4H—atherosclerosis	6.63e-06	0.000709	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	6.52e-06	0.000697	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPA—atherosclerosis	6.45e-06	0.000689	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BGN—atherosclerosis	6.24e-06	0.000668	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA5—atherosclerosis	6.18e-06	0.000661	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	5.95e-06	0.000636	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.89e-06	0.00063	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALOX5—atherosclerosis	5.75e-06	0.000614	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.53e-06	0.000591	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.24e-06	0.00056	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NAMPT—atherosclerosis	5.15e-06	0.000551	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LIPC—atherosclerosis	5.12e-06	0.000548	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOC3—atherosclerosis	5.09e-06	0.000544	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LDLR—atherosclerosis	5.06e-06	0.000541	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CETP—atherosclerosis	4.94e-06	0.000528	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LCAT—atherosclerosis	4.93e-06	0.000527	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—FABP4—atherosclerosis	4.93e-06	0.000527	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.85e-06	0.000519	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA4—atherosclerosis	4.84e-06	0.000517	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.75e-06	0.000508	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SCARB1—atherosclerosis	4.73e-06	0.000506	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMGCR—atherosclerosis	4.47e-06	0.000478	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.39e-06	0.00047	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	4.38e-06	0.000468	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.16e-06	0.000445	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.16e-06	0.000445	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.16e-06	0.000445	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA2—atherosclerosis	4.16e-06	0.000445	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.11e-06	0.00044	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ABCA1—atherosclerosis	3.98e-06	0.000426	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPA—atherosclerosis	3.97e-06	0.000425	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BGN—atherosclerosis	3.85e-06	0.000411	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA5—atherosclerosis	3.81e-06	0.000407	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.67e-06	0.000392	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.54e-06	0.000379	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—atherosclerosis	3.42e-06	0.000365	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOB—atherosclerosis	3.27e-06	0.00035	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTM1—atherosclerosis	3.18e-06	0.00034	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.18e-06	0.00034	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LIPC—atherosclerosis	3.16e-06	0.000337	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOC3—atherosclerosis	3.14e-06	0.000335	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—LPL—atherosclerosis	3.13e-06	0.000334	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LDLR—atherosclerosis	3.12e-06	0.000333	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GPX1—atherosclerosis	3.05e-06	0.000326	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CETP—atherosclerosis	3.04e-06	0.000325	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CD36—atherosclerosis	2.97e-06	0.000318	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.92e-06	0.000312	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—MTHFR—atherosclerosis	2.81e-06	0.000301	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARA—atherosclerosis	2.76e-06	0.000295	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.75e-06	0.000294	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AGT—atherosclerosis	2.67e-06	0.000286	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOE—atherosclerosis	2.62e-06	0.00028	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CAV1—atherosclerosis	2.6e-06	0.000278	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—APOA1—atherosclerosis	2.59e-06	0.000277	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.45e-06	0.000262	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CG—atherosclerosis	2.36e-06	0.000253	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PPARG—atherosclerosis	2.28e-06	0.000244	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—INS—atherosclerosis	2.24e-06	0.000239	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.11e-06	0.000225	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALB—atherosclerosis	2.05e-06	0.000219	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOB—atherosclerosis	2.02e-06	0.000216	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—atherosclerosis	1.96e-06	0.00021	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.96e-06	0.00021	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—LPL—atherosclerosis	1.93e-06	0.000206	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GPX1—atherosclerosis	1.88e-06	0.000201	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CD36—atherosclerosis	1.83e-06	0.000196	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—atherosclerosis	1.8e-06	0.000192	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.73e-06	0.000185	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARA—atherosclerosis	1.7e-06	0.000182	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AGT—atherosclerosis	1.65e-06	0.000176	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOE—atherosclerosis	1.61e-06	0.000173	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CAV1—atherosclerosis	1.6e-06	0.000171	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—APOA1—atherosclerosis	1.6e-06	0.000171	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.46e-06	0.000156	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PPARG—atherosclerosis	1.41e-06	0.00015	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—INS—atherosclerosis	1.38e-06	0.000147	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALB—atherosclerosis	1.26e-06	0.000135	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—atherosclerosis	1.21e-06	0.000129	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.11e-06	0.000118	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—AKT1—atherosclerosis	9.02e-07	9.65e-05	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—AKT1—atherosclerosis	5.56e-07	5.94e-05	CbGpPWpGaD
